AIG spin-off Corebridge $CRBG, in what could be the largest deal of 2022 so far, plans to raise $1.8 billion at a fully diluted market value of $14.7 billion-week next week. Six other deals are expected to begin trading in the week ahead including biotech Third Harmonic Bio (THRD), China based Lichen China (LICN), neurostimulation medical device maker Nexalin Technology (NXL) and non-invasive neural input technology company Wearable Devices (WLDS). Two companies are planning to up list from the OTC. Pennsylvania-based The Gratz Bank LINKBANCORP (LNKB) and Bio- … Continue reading “US Weekly IPO and SPAC Monitor: AIG spin-off Corebridge, Third Harmonic Bio and LINKBANCORP”